These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2873981)

  • 21. [Acetylation phenotype in patients with cancer of the bladder. Preliminary report].
    Skretowicz J; Polakowski P; Jeromin L; Zasada M; Szymańska J; Krajewska B
    Med Pr; 1988; 39(4):241-5. PubMed ID: 3237058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acetylation phenotype and biotransformation of various drugs].
    Grygorowicz J; Januszko J
    Wiad Lek; 1987 Mar; 40(5):319-23. PubMed ID: 3303698
    [No Abstract]   [Full Text] [Related]  

  • 23. Extrahepatic expression of N-acetylator genotype in the inbred hamster.
    Hein DW; Kirlin WG; Ogolla F; Trinidad A
    Drug Metab Dispos; 1987; 15(1):68-73. PubMed ID: 2881761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ecogenetic studies of drug acetylation in man and rats.
    Dubbels R; Khoory R; Schloot W
    Acta Anthropogenet; 1981; 5(2):111-8. PubMed ID: 7271997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
    Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inheritance of liver N-acetyltransferase activity in the rapid and slow acetylator inbred hamster.
    Hein DW; Kirlin WG; Ferguson RJ; Weber WW
    J Pharmacol Exp Ther; 1985 Jun; 233(3):584-7. PubMed ID: 3874278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Variability of isoniazid pharmacokinetics].
    Sokolova GB; Ivleva AIa; Ziia AV; Vilenskaia RN
    Farmakol Toksikol; 1982; 45(3):101-4. PubMed ID: 7095118
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains.
    Hein DW; Smolen TN; Fox RR; Weber WW
    J Pharmacol Exp Ther; 1982 Oct; 223(1):40-4. PubMed ID: 7120125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylation of acetylhydrazine, the toxic metabolite of isoniazid, in humans. Inhibition by concomitant administration of isoniazid.
    Peretti E; Karlaganis G; Lauterburg BH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):686-9. PubMed ID: 3681700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Testing for heterogeneity in genetic polymorphism of N-acetylation using isoniazid by metameters--probit, logit, and arcsine transformation].
    Kohno H; Mori M; Katayama T
    Kekkaku; 1993 Aug; 68(8):511-6. PubMed ID: 8377325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of 5-aminoquinoline with liver cytosol enzyme.
    Banoo R; Matheison DW
    Indian J Biochem Biophys; 1993 Aug; 30(4):229-33. PubMed ID: 8276426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetyl-CoA dependent O-acetylation of N-hydroxyarylamines in bacterial and mammalian cells--the significance for mutagenesis and carcinogenesis.
    Kato R; Kamataki T; Saito K; Shinohara A
    Prog Clin Biol Res; 1986; 209A():507-14. PubMed ID: 3529109
    [No Abstract]   [Full Text] [Related]  

  • 33. Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamster.
    Hein DW; Kirlin WG; Ferguson RJ; Weber WW
    J Pharmacol Exp Ther; 1985 Aug; 234(2):358-64. PubMed ID: 3874952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of a caffeine test for determining the phenotype of N-acetyltransferase].
    Gascon MP; Leemann T; Dayer P
    Schweiz Med Wochenschr; 1987 Dec; 117(49):1974-6. PubMed ID: 3423781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of arylhydroxamic acid N,O-acyltransferase and genetically polymorphic N-acetyltransferase in established inbred rabbit strains.
    Weber WW; Hein DW; Glowinski IB; King CM; Fox RR
    IARC Sci Publ; 1982; (39):405-12. PubMed ID: 7152617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Isoniazid metabolism in the small-intestinal wall of rats].
    Lutosławska G
    Acta Pol Pharm; 1981; 38(6):711-5. PubMed ID: 7348531
    [No Abstract]   [Full Text] [Related]  

  • 37. Acetylator status, drug metabolism and disease.
    Pande JN; Pande A; Singh SP
    Natl Med J India; 2003; 16(1):24-6. PubMed ID: 12715953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9).
    De Leon JH; Martell KJ; Vatsis KP; Weber WW
    Drug Metab Dispos; 1995 Dec; 23(12):1354-61. PubMed ID: 8689943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic activation of carcinogenic arylamines by rapid acetylator, slow acetylator, and chimeric recombinant Syrian hamster NAT2 allozymes.
    Hein DW; Doll MA; Ferguson RJ
    Proc West Pharmacol Soc; 1995; 38():59-62. PubMed ID: 7480023
    [No Abstract]   [Full Text] [Related]  

  • 40. [Polymorphic acetylation in women with genital neoplasms].
    Tomaszkiewicz T; Markowska J; Simm S; Herwichowska K
    Pol Tyg Lek; 1979 Sep; 34(39):1521-3. PubMed ID: 503961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.